McKesson Specialty Distribution LLC awarded $210M for centralized vaccine distribution services

Contract Overview

Contract Amount: $210,451,958 ($210.5M)

Contractor: Mckesson Specialty Distribution LLC

Awarding Agency: Department of Health and Human Services

Start Date: 2011-12-12

End Date: 2017-06-05

Contract Duration: 2,002 days

Daily Burn Rate: $105.1K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 2

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: CENTRALIZED VACCINE DISTRIBUTION

Place of Performance

Location: MEMPHIS, SHELBY County, TENNESSEE, 38115

State: Tennessee Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $210.5 million to MCKESSON SPECIALTY DISTRIBUTION LLC for work described as: CENTRALIZED VACCINE DISTRIBUTION Key points: 1. The contract value of $210.46 million over its period of performance suggests a significant investment in vaccine logistics. 2. The use of a definitive contract indicates a long-term relationship for a critical service. 3. The fixed-price nature of the contract provides cost certainty for the government. 4. The contract was awarded under full and open competition, implying a robust bidding process. 5. The service falls under refrigerated warehousing and storage, a specialized logistical niche. 6. The award to a single contractor, McKesson Specialty Distribution LLC, highlights their role in this specific supply chain.

Value Assessment

Rating: good

The contract value of over $210 million for centralized vaccine distribution over approximately five years appears reasonable given the critical nature of vaccine supply chain management. Benchmarking against similar large-scale distribution contracts is challenging without more specific service details, but the scale suggests a significant operational footprint. The firm fixed-price structure helps control costs, though the total value reflects the comprehensive services required.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, indicating that multiple qualified vendors had the opportunity to bid. The presence of two bids suggests a competitive environment, though the specifics of the bidding process and the reasons for only two submissions are not detailed. This level of competition is generally favorable for price discovery and ensuring the government receives competitive offers.

Taxpayer Impact: Full and open competition generally leads to better pricing for taxpayers by encouraging multiple vendors to offer their best terms and pricing to secure the contract.

Public Impact

The primary beneficiaries are the public, who receive access to essential vaccines through a reliable distribution network. The service delivered is the secure and temperature-controlled storage and distribution of vaccines. The geographic impact is national, ensuring vaccine availability across the United States. Workforce implications include jobs in logistics, warehousing, transportation, and administrative support for the contractor.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

The contract falls within the broader logistics and supply chain management sector, specifically focusing on cold chain storage and distribution for pharmaceuticals. This is a critical sub-sector for public health, requiring specialized infrastructure and adherence to strict regulatory standards. The market for such services is competitive, with several large players capable of handling national-scale distribution, but specialized capabilities like cold chain are a key differentiator.

Small Business Impact

The data indicates that small business participation was not a primary focus for this contract, as it was not set aside for small businesses and the contractor is a large entity. There is no explicit information on subcontracting plans with small businesses. This suggests that the primary award went to a large, established firm capable of meeting the extensive requirements of national vaccine distribution.

Oversight & Accountability

Oversight for this contract would typically be managed by the Centers for Disease Control and Prevention (CDC) through contract officers and technical representatives. Accountability measures are embedded in the contract terms, including performance standards and reporting requirements. Transparency is generally maintained through contract award databases, though detailed operational performance data may be proprietary. Inspector General jurisdiction would apply in cases of fraud, waste, or abuse.

Related Government Programs

Risk Flags

Tags

healthcare, logistics, vaccine-distribution, cold-chain, department-of-health-and-human-services, centers-for-disease-control-and-prevention, mckesson-specialty-distribution-llc, definitive-contract, firm-fixed-price, full-and-open-competition, refrigerated-warehousing, national

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $210.5 million to MCKESSON SPECIALTY DISTRIBUTION LLC. CENTRALIZED VACCINE DISTRIBUTION

Who is the contractor on this award?

The obligated recipient is MCKESSON SPECIALTY DISTRIBUTION LLC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Centers for Disease Control and Prevention).

What is the total obligated amount?

The obligated amount is $210.5 million.

What is the period of performance?

Start: 2011-12-12. End: 2017-06-05.

What is McKesson Specialty Distribution LLC's track record with government contracts, particularly in healthcare logistics?

McKesson Specialty Distribution LLC, a subsidiary of McKesson Corporation, has a long history of managing complex supply chains, including pharmaceuticals and medical supplies, for both commercial and government entities. They are a major player in the healthcare distribution market. Their track record with government contracts, particularly with agencies like the Department of Health and Human Services (HHS) and the Department of Defense (DoD), includes managing large-scale distribution networks, handling sensitive materials, and ensuring regulatory compliance. While specific contract performance details are often not publicly disclosed in full, McKesson's sustained presence and significant contract awards in this sector suggest a generally reliable performance history. Their expertise in cold chain logistics is a key factor in their ability to secure and execute contracts for vaccine distribution.

How does the $210.46 million contract value compare to similar centralized vaccine distribution contracts awarded by the government?

Direct comparisons for centralized vaccine distribution contracts can be difficult due to variations in scope, duration, specific services (e.g., warehousing only vs. end-to-end distribution), and the types of vaccines handled. However, the $210.46 million awarded to McKesson Specialty Distribution LLC over approximately five years (from late 2011 to mid-2017) represents a substantial investment. This figure aligns with the scale of operations required for national vaccine logistics, especially considering the need for secure, temperature-controlled storage and timely delivery to numerous points. For context, other large federal contracts for pharmaceutical logistics or medical supply chain management often run into hundreds of millions of dollars, reflecting the complexity and critical nature of these services. The value suggests a comprehensive service offering rather than a simple warehousing agreement.

What are the primary risks associated with awarding a large, long-term contract for vaccine distribution to a single entity?

Awarding a large, long-term contract for a critical service like vaccine distribution to a single entity, such as McKesson Specialty Distribution LLC in this case, presents several key risks. Firstly, there's the risk of 'single point of failure.' If the contractor experiences significant operational disruptions—due to natural disasters, labor disputes, cyberattacks, or financial instability—the entire national vaccine supply chain could be jeopardized, leading to shortages and public health crises. Secondly, over-reliance on one contractor can reduce government leverage over time, potentially leading to complacency or less aggressive cost management by the contractor. Thirdly, a lack of ongoing competition might stifle innovation in logistics and distribution methods. Finally, the government's ability to pivot to alternative solutions or contractors in an emergency could be limited by the entrenched nature of the existing contract and the specialized infrastructure the single provider operates.

What does the 'firm fixed price' contract type imply about cost management and potential for overruns?

A 'firm fixed price' (FFP) contract type, like the one awarded to McKesson Specialty Distribution LLC, implies that the contractor agrees to a set price for the defined scope of work, regardless of the actual costs incurred. This structure places the primary risk of cost overruns on the contractor. For the government, it offers significant cost certainty and predictability, making budgeting easier. It incentivizes the contractor to manage its costs efficiently to maximize profit. Potential overruns are less likely to impact the government's budget directly, unless there are contract modifications or scope changes. However, contractors may build in higher contingency amounts into their initial FFP bids to account for potential risks, which could result in a higher baseline price compared to other contract types if risks do not materialize.

How does the contract's duration (2002 days) and award type ('Definitive Contract') influence the overall value and risk?

The contract duration of 2002 days, approximately 5.5 years, combined with the 'Definitive Contract' award type, signifies a long-term commitment by the government to McKesson Specialty Distribution LLC for centralized vaccine distribution. A definitive contract is typically used for substantial requirements over a period of time, often with a defined scope and price. This long duration provides stability for both the government and the contractor, allowing for significant investment in infrastructure and processes. For the government, it ensures continuity of a critical service. For the contractor, it offers a predictable revenue stream. The risk associated with this long duration is that market conditions, technological advancements, or the government's needs might change significantly over 5.5 years, potentially making the contracted services less optimal or more expensive than alternatives that might emerge. However, the firm fixed-price nature helps mitigate budget risk for the government.

What is the significance of the North American Industry Classification System (NAICS) code 493120 (Refrigerated Warehousing and Storage)?

The NAICS code 493120, 'Refrigerated Warehousing and Storage,' is highly significant as it precisely defines the core service provided under this contract. This classification indicates that the contract is focused on the specialized infrastructure and operational capabilities required to store goods at controlled, low temperatures. For vaccine distribution, this is paramount, as most vaccines require strict cold chain maintenance (typically between 2°C and 8°C, with some requiring ultra-low temperatures) to remain effective. Awarding the contract under this NAICS code signals that the government specifically sought vendors with the necessary facilities, equipment (e.g., walk-in coolers, freezers, temperature monitoring systems), and expertise in managing temperature-sensitive inventory, including handling, tracking, and transportation protocols to maintain product integrity throughout the supply chain.

Industry Classification

NAICS: Transportation and WarehousingWarehousing and StorageRefrigerated Warehousing and Storage

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT)ADMINISTRATIVE SUPPORT SERVICES

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: 2011N13279

Offers Received: 2

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Mckesson Corporation

Address: 1220 SENLAC DR, CARROLLTON, TX, 75006

Business Categories: Category Business, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $501,605,316

Exercised Options: $448,940,289

Current Obligation: $210,451,958

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Timeline

Start Date: 2011-12-12

Current End Date: 2017-06-05

Potential End Date: 2017-06-05 00:00:00

Last Modified: 2024-01-31

More Contracts from Mckesson Specialty Distribution LLC

View all Mckesson Specialty Distribution LLC federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending